Panobacumab

From Wikipedia, the free encyclopedia
Panobacumab ?
Monoclonal antibody
Type Whole antibody
Source Human
Target Pseudomonas aeruginosa serotype IATS O11
Clinical data
Legal status ?
Identifiers
CAS number 885053-97-4 N
ATC code None
UNII 62B4OXU259 YesY
Chemical data
Formula C38714H60189N10637O12187S322 
Mol. mass 879.9 kDa
 N (what is this?)  (verify)

Panobacumab (proposed INN) is a monoclonal antibody designed as an antibacterial against Pseudomonas aeruginosa.[1]

It is a fully human pentameric IgM antibody with a mouse J chain.[1]

Panobacumab molecule consisting of five base units.
1: Base unit.
2: Heavy chains.
3: Light chains.
4: J chain.
5: Intermolecular disulfide bonds.

References

  1. ↑ 1.0 1.1 International Nonproprietary Names for Pharmaceutical Substances (INN, prepublication copy), World Health Organization.
Monoclonal antibodies for infectious disease and toxins
Fungal ("-fung-")
Human ("-fungu-")
Viral ("-vi(r)-")
Human ("-viru-")
Humanized ("-vizu-")
Bacterial ("-ba(c)-")
Human ("-bacu-")
Mouse ("-baco-")
Chimeric ("-baxi-")
Humanized ("-bazu-")
Toxin ("-tox(a)-")
Human ("-toxu-")
Humanized ("-toxazu-")


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.